Diagnostic accuracy of plasma brain natriuretic peptide and aminoterminal-proBNP in mild heart failure depends on assay and introduction of therapy

Scandinavian Journal of Clinical and Laboratory Investigation

Volumn 65, Issue 8, 2005, Pages 633-648

  Mikkelsen, K V ^a,d   Bie, P ^b   Moller J E ^a   Ryde, H ^c   Videbaek L ^a   Haghfelt, T ^a  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

^b UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^c SLAGELSE HOSPITAL   (Denmark)

^d NONE   (Denmark)

Author keywords

Biochemical marker; Correlation; Echocardiography; Heart failure with preserved systolic function; Therapeutic intervention

Indexed keywords

BIOCHEMICAL MARKER; BRAIN NATRIURETIC PEPTIDE;

AGED; AMINO TERMINAL SEQUENCE; ANTIBODY DETECTION; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC APPROACH ROUTE; DOPPLER ECHOCARDIOGRAPHY; FEMALE; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FILLING PRESSURE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; RECEIVER OPERATING CHARACTERISTIC; ROC CURVE; SYSTOLIC BLOOD PRESSURE;

EID: 28744448257     PISSN: 00365513     EISSN: 15027686     Source Type: Journal    
DOI: 10.1080/00365510500333577     Document Type: Article

References (28)

1. Hobbs FDR, Jones MI, Allan TF, Wilson S, Tobias R. European survey of primary care physician perceptions on heart failure diagnosis and management (Euro-HF). Eur Heart J 2000;21:1877-87.
2. Badgett RG, Lucey CR, Mulrow CD. Can the clinical examination diagnose left-sided heart failure in adults? JAMA 1997;277:1712-9.
3. Caruana L, Petrie MC, Davie AP, McMurray JJV. Do patients with suspected heart failure and preserved left ventricular systolic function suffer from "diastolic heart failure" or from misdiagnosis? A prospective descriptive study. Br Med J 2000;321:215-9.
4. Levin ER, Gardner DG, Samson WK. Natriuretic peptides. N Engl J Med 1998;339:321-8.
5. Goetze JP, Christoffersen C, Perko M, Arendrup H, Rehfeld JF, Kastrup J, et al. Increased cardiac BNP expression associated with myocardial ischemia. FASEB J 2003;9:1105-7.
6. Doust JA, Glasziou PP, Petrzak E, Dobson AJ. A systematic review of the diagnostic accuracy of natriuretic peptides for heart failure. Arch Intern Med 2004;164:1978-84.
7. Vogeser M, Jacob K. B-type natriuretic peptide (BNP)-validation of an immediate response assay. Clin Lab 2001;47:29-33.
8. Hammerer-Lercher A, Ludwig W, Falkensammer G, Müller S, Neubauer E, Puschendorf B, et al. Natriuretic peptides as markers of mild forms of left ventricular dysfunction: effects of assays on diagnostic performance of markers. Clin Chem 2004;50:1174-83.
9. Mueller T, Gegenhuber A, Poeltz W, Haltmayer M. Comparison of the Biomedica NT-proBNP enzyme immunoassay and Roche NT-proBNP chemiluminescence immunoassay: implications for the prediction of symptomatic and asymptomatic structural heart disease. Clin Chem 2003;49:976-9.
10. American Society of Echocardiography Committee on Standards. Recommendations for quantification of the left ventricle by two-dimensional echocardiography. J Am Soc Echocardiogr 1989;2:358-67.
11. Oh JK, Appleton CP, Hatle LJ, Nishimura RA, Seward JB, Tajik AJ. The non-invasive assessment of left ventricular diastolic function with two-dimensional and Doppler echocardiography. J Am Soc Echocardiogr 1997;10:246-70.
12. Khouri SJ, Maly GT, Suh DD Walsh TE. A practical approach to the echocardiographic evaluation of diastolic function. Am Soc Echocardiogr 2004;17:290-7.
13. European Study Group on Diastolic Heart Failure. How to diagnose diastolic heart failure. Eur Heart J 1998;19:990-1003.
14. Masson S, Vago T, Baldi G, Salio M, De Angelis N, Nicolis E, et al. Comparative measurement of N-terminal pro brain natriuretic peptide and brain natriuretic peptide in ambulatory patients with heart failure. Clin Chem Lab Med 2002;40:761-3.
15. Schulz H, Langvik TA, Smith J, Sagen EL, Smith J, Ahmadi N, et al. Radioimmunoassay for N-terminal probrain natriuretic peptide in human plasma. Scand J Clin Lab Invest 2001;61:33-42.
16. Seidler T, Pemberton C, Yandle T, Espiner E, Nicolis G, Richards M. The amino terminal regions of proBNP and proANP oligomerize through leucine zipper-like coiled-coil motifs. Biochem Biophys Res Commun 1999;255:495-501.
17. Shimizu H, Masuta K, Asada H, Sugita K, Sairenji T. Characterization of molecular forms of probrain natriuretic peptide in human plasma. Clin Chim Acta 2004;334:233-9.
18. Goetze JP, Rehfeld JF, Videbaek R, Friis-Hansen L, Kastrup J. B-type natriuretic peptide and its precursor in cardiac venous blood from failing hearts. Eur J Heart Fail 2005;7:69-74.
19. Goetze JP, Kastrup J, Pedersen F, Rehfeld JF. Quantification of pro-B-type natriuretic peptide and 1st products in human plasma by use of an analysis independent precursor processing. Clin Chem 2002;48:1025-42.
20. Vanderheyden M, Bartunek J, Goethals M. Brain and other natriuretic peptides: molecular aspects. Eur J Heart Fail 2004;6:261-8.
21. Bossuyat PM, Reitsma JB, Bruns DE, Gatsonis CA, Glasziou PP, Irwig LM, et al. for the STARD group. Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. Clin Chem 2003;49:1-6.
22. Bossuyat PM, Reitsma JB, Bruns DE, Gatsonis CA, Glasziou PP, Irwig LM, et al. The STARD statement for reporting studies of diagnostic accuracy: explanation and elaboration. Clin Chem 2003;49:7-18.
23. Obuchowski NA, Lieber ML, Wians FH. ROC curves in clinical chemistry: uses, misuses and possible solutions. Clin Chem 2004;50:1118-25.
24. McGeoch G, Lainchbury J, Town G, Toop L, Espiner E, Richards AM. Plasma brain natriuretic peptide after long-term treatment for heart failure in general practice. Eur J Heart Fail 2002;4:479-83.
25. Tang WHW, Girod JP, Lee MJ, Starling RC, Young JB, Van Lente F, et al. Plasma B-type peptide levels in ambulatory patients with established chronic symptomatic systolic heart failure. Circulation 2003;108:2964-6.
26. Bellenger NG, Burgess MI, Ray SG, Lahiri A, Coats AJS, Cleland JGF, et al. Comparison of left ventricular ejection fraction and volumes in heart failure by echocardiography, radionuclide ventriculography and cardiovascular magnetic resonance. Are they interchangeable? Eur Heart J 2000;21:1387-96.
27. Møgelvang J, Stokholm KH, Saunamäki K, Reiner A, Stubgaard M, Thomsen C, et al. Assessment of left ventricular volumes by magnetic resonance in comparison with radionuclide angiography, contrast angiography and echocardiography. Eur Heart J 1992;13:1677-83.
28. Poulsen SH, Andersen NH, Ivarsen PI, Mogensen CE, Egeblad H. Doppler tissue imaging reveals systolic dysfunction in patients with hypertension and apparent "isolated" diastolic dysfunction. J Am Soc Echocardiogr 2003;16:724-31.